Skip to the content
 
  • Payment Plans
  • Login for Professionals
  • English
    • Deutsch
    • Français
    • Italiano
    • English
  • Healthy Travelling
  • Countries
  • News
  • Special travellers
  • Health risks
  • Vaccinations
  • Ask a specialist

MENU

  • LogIn
  • English
    • Deutsch
    • Français
    • Italiano
    • English
  • Healthy Travelling
  • Countries
  • News
  • Special travellers
  • Health risks
  • Vaccinations
  • Ask a specialist
 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

The Democratic Republic of the Congo's (DRC) 17th Ebola outbreak, caused by the Bundibugyo virus and declared a Public Health Emergency of International Concern (PHEIC) on 17 May 2026, has been spreading across the provinces of Ituri, North Kivu, and South Kivu, with confirmed cross-border transmission into the Ugandan capital, Kampala.

 

Critical containment gaps, including insecurity and conflict, a contact follow-up rate well below the target level, infections among healthcare workers, deficiencies in infection prevention and control (IPC), and a funding shortfall, are sustaining transmission. The absence of an approved vaccine for this species of ebolavirus limits the range of available countermeasures.

 

On 2 June 2026, WHO reported that the number of suspected cases in the DRC had decreased compared to previous reports after many were ruled out through investigation and testing. This decline reflects case reclassification rather than necessarily reduced transmission.

 

D.R. Congo: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):

  • Cases: 379 confirmed and 303 suspected cases.
    Confirmed cases have been reported from Ituri (> 340 confirmed cases in 17 health zones), North Kivu (19 confirmed cases in seven health zones) and South Kivu provinces (three cases from one health zone),
  • Deaths: 63 confirmed and 259 suspected deaths.
  • Active cases: 238 confirmed cases.
  • Recoveries: 6 cases.
  • Contacts: The overall contact follow-up rate in the DRC was 43.6%, below the operational target of 95%. 
  • Operational update: Bunia airport in Ituri Province reopened after a previous suspension of passenger flights. Screening measures have been put in place.
  • Operational challenges:
    • Information regarding transmission chains and affected population groups is currently limited, partly due to the complex context of ongoing insecurity and humanitarian challenges in the affected areas.

 

Uganda: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):

  • Cases, deaths: a total of 16 confirmed cases, including one death have been reported.
  • Location: At least seven cases were associated with local transmission events and four with travel links to DRC, according to health officials. Of nine cases with known geographical information, eight cases were reported in Kampala, except one case that was reported in the neighbouring district of Wakiso. Three of the cases have travel links to DRC and five are contacts linked to the first two cases, including 3 healthcare workers.
  • Contacts: As of 02 June, 668 contacts have been identified and are being closely monitored / followed up.

 

Outside Africa:

  • One confirmed BVD case involving a US surgeon is still hospitalized in Berlin, Germany as well as six contacts. Another contact was to be transferred to Czechia.
  • Kenya investigated 22 Ebola alerts across nine counties, all of which tested negative. The country also strengthened surveillance, designated Ebola testing laboratories, expanded isolation capacity at national and county levels, and enhanced screening at priority points of entry.
  • Several symptomatic travellers from affected areas have been tested in EU/EEA and non-EU/EEA
    countries, all of which were negative so far.

 

Entry and exit screenings and control measures:

  • Several countries and territories reported additional border health or travel-related measures. For most UpToDate information, see IATA LINK.

 

Authorities are concerned about the risk of further spread due to population high mobility, insecurity, and the proximity of affected areas to Uganda and South Sudan through a porous border.

Distribution of suspected and confirmed Bundibugyo virus disease cases in the Democratic Republic of the Congo and Uganda, as of 6 June 2026:

 

Ebola.JPG

WHO assesses the risk of the epidemic as very high at the national level, high at regional levels, and low at the global level (including Switzerland and the EU/EEW). For details, see LINK.

ECDC assesses the risk for EU/EEA travellers in affected areas as low if precautions (see under “consequences for travelers”) are followed but emphasizes uncertainties and rapid evolution.

 

Due to the very recent declaration of the outbreak and the uncertainties related to the
epidemiological information, it is probable that the outbreak is much larger than what is currently
being reported – not only in regards to the number of affected cases, but also in its geographical extent.

 

The situation is evolving rapidly! Always stay informed before, during, and after travel! As of 11 June 2026:

  • Avoid non-essential travel to the affected areas in DRC (provinces of Ituri, North Kivu, South Kivu), and to nearby areas in neighboring countries, also due to the security situation (see EDA).
  • For travel in Uganda and the DRC outside the affected areas: Keep yourself regularly updated via official sources. Be aware that conditions can change rapidly. Access to medical care - for accidents, fever, or other health concerns - may be limited and challenging and may involve risks, as may medical evacuation.

The following precautions are recommended for all travel to the DRC and Uganda as well as in neighboring countries:

 

General preventive measures:

  • Wash hands regularly and carefully using soap and water (or alcohol gel if soap is unavailable).
  • Avoid contact with sick people who have symptoms, such as fever, muscle pain, and rash.
  • Avoid contact with blood and other body fluids.
  • Avoid visiting healthcare facilities in the affected areas for nonurgent medical care or non-medical reasons.
  • Avoid contact with dead bodies or items that have been in contact with dead bodies, participating in funeral or burial rituals, or attending a funeral or burial. 
  • Avoid handling, cooking, or eating bush/wild meat (meat of wild/feral mammals killed for food).
  • Wash and peel fruit and vegetables before consumption.
  • Avoid visiting mines or bat caves and contact with all wild animals; alive or dead, particularly bats and the great apes.
  • Practice safer sex.
  • Stay informed for entry and exit requirements by countries, see IATA LINK.
  • If you feel unwell during flight, inform crew immediately and avoid close physical contact with other passengers.

Of note: there is currently no licensed vaccine or specific treatment against Ebola diseased caused by Bundibugyo virus. For humanitarian missions, consultation with a travel medicine specialist is recommended.

 

 

While in the affected areas in DRC and in Uganda and for 21 days after leaving:
  • Watch for symptoms (see below).
  • Expect health screening at departure.
  • Stay reachable if contacted by health authorities.
  • Follow quarantine measures established by your local health authorities.

 

! In case of symptoms headache, body aches, muscle pain, fatigue, loss of appetite, vomiting or diarrhea during your stay in and for 21 days after leaving north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and /or Uganda, especially the affected areas:

  • Separate yourself from others (isolate) immediately.
  • Do not travel.
  • By phone: contact local health authorities or a healthcare facility for a thorough evaluation of your risk (e.g. tropical institute or travel clinic or university hospital infectious disease unit).
  • Always state that you were in the affected areas and you may have had a possible exposure to Ebola (incubation period: 2-21 days). 
  • While under investigation as a suspected case, please also raise the issue of a malaria test and other investigations.
  • Details for Ebola disease: see BAG and RKI (in German) or ECDC (in English).

Recommendations of the Swiss Expert Committee for Travel Medicine (as of 11 June 2026, subject to change according to the evolving situation):
A suspected case is:

  1. A symptomatic person (see FOPH case definition) with a history of stay within the last 21 days in north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and/or Uganda. 
                              AND
  2. Having had a high-risk exposure* - evaluated by a specialist in tropical medicine or infectious diseases (in case of doubt, contact the Geneva Reference Centre for Emerging Virus Diseases).

Such cases should be isolated, tested, and reported to the Cantonal Physician and the Swiss Federal Office of Public Health within 2 hours.

 

*High-risk exposure includes:

  • Participation in local funerals; or
  • Contact with a sick patient, their body fluids, and/or contaminated material, at home, during transport, or in a healthcare facility; or
  • Attendance at a local healthcare facility.
  • Direct contact with bats, rodents, non-human primates, living or dead, in or from Ebola disease affected areas, or bushmeat.
  • Having unprotected sexual contact with a case up to six months after recovery.
 
WHO Ebola Portal, accessed 3.6.2026 | ECDC, accessed 3.6.2026 | WHO DON, 29.5.2026 | Reuters, 2.6.2026 | Via BEACON, 4.6.2026

 

On 15 May 2026, the DRC declared a Bundibugyo Ebola outbreak, while Uganda reported two imported cases. WHO declared a Public Health Emergency of International Concern (PHEIC) on 16 May, see EpiNews 21.5 2026.

 

As of 26 May 2026:

D.R. Congo:

  • Cases: More than 1’100 cases (>1000 suspected, >120 confirmed cases). Confirmed cases have been reported from Ituri (110 confirmed cases), North Kivu (11 confirmed cases) and South Kivu provinces (one confirmed death).
  • Deaths: 246 suspected and 17 confirmed deaths. Of the confirmed deaths, 14 deaths were individuals over 15 years of age, while three were under 15.
  • Location: Cases have been reported in three provinces: Ituri (16 health zones), North Kivu (2 health zones), and South Kivu (1 health zone).
  • Contacts: As of 25 May, more than 2’231 contacts have been identified, with approximately 20% under follow-up. The laboratory test positivity rate in DRC is currently 30.0%.
  • Operational update: Bunia airport, DRC, has been temporarily closed.
  • Operational challenges:
    • Information regarding transmission chains and affected population groups is currently limited, partly due to the complex context of ongoing insecurity and humanitarian challenges in the affected areas.
    • Several sources have reported local protests and arson attacks targeting treatment centres with escape of at least 25 suspected cases. Citizens burned two tents in a hospital section treating Ebola patients. Volunteers have also faced intimidation and threats from armed groups in Bunia.

WHO expects those numbers to keep increasing, given the amount of time the virus was circulating before the outbreak was detected.

 

Uganda:

  • Cases, deaths: a total of seven confirmed cases, including one death have been reported. Three of the cases have travel links to DRC and five are contacts linked to the first two cases, including 3 healthcare workers.
  • Location: Cases have been diagnosed and are hospitalized in Kampala.
  • Contacts: As of 24 May, 311 contacts linked to the confirmed cases have been identified and are being closely monitored and followed up.

 

Further cases:

  • One confirmed BVD case involving a US surgeon who had worked in the affected area in DRC was transferred to Germany and is hospitalised in Berlin alongside six high-risk contacts. One additional contact was transferred to the Czech Republic.
  • On 27 May, an asymptomatic Italian doctor returning from Ituri (DRC) after exposure to confirmed cases was placed in quarantine in Rome.
  • South Sudan is investigating a suspected Bundibugyo virus disease case in West Equatoria State after a preliminary positive result in a patient from South Yambio County.

 

Exit screening and control measures:

  • Regional: Exit screening and health control measures have been implemented for travellers from DRC, Uganda, and South Sudan.
  • Uganda has ceased air travel to DRC, closed multiple border crossings, and increased border crossing screenings (LINK).
  • Rwanda: Reinforced health screening at land border crossings with DRC and enhanced entry screening at Kigali International Airport for inbound travellers to Rwanda.
  • United States: Introduced enhanced entry screening measures and established a regional Ebola quarantine and treatment facility in Kenya for exposed or infected US citizens.
  • Canada: Temporary entry restrictions for residents of DRC, Uganda, and South Sudan effective from 27 May for 90 days. From 30 May, asymptomatic Canadian citizens and residents returning from high-risk areas will be subject to a 21-day quarantine.
  • For other countries, see IATA LINK which will be constantly updated.

Authorities are concerned about the risk of further spread due to population high mobility, insecurity, and the proximity of affected areas to Uganda and South Sudan through a porous border.

 

Distribution of suspected and confirmed Bundibugyo virus disease cases in the Democratic Republic of the Congo and Uganda, as of 24 May 2026:

 

Ebola.png

WHO assesses the risk of the epidemic as very high at the national level, high at regional levels, and low at the global level (including Switzerland and the EU/EEW). For details, see LINK.

ECDC: Due to the very recent declaration of the outbreak and the uncertainties related to the
epidemiological information, it is probable that the outbreak is much larger than what is currently
being reported – not only in regard to the number of affected cases, but also to its geographical
extent.

ECDC assesses the risk for EU/EEA travellers in affected areas as low if precautions (see below) are followed but emphasizes uncertainties and rapid evolution.

 

ECDC considers that screening of returning travellers from affected areas (DRC, Uganda) would not be an effective measure to prevent introduction to Europe. This consideration is based on the lessons learned and results of the large EVD outbreak in West Africa between 2013 and 2016, where tens of thousands of cases were reported, transmission was ongoing in large urban centres, and hundreds of EU/EEA humanitarian and military personnel were deployed to the affected areas. Screening incoming travellers is time- and resource-consuming and will not effectively identify infected cases.

 

Priority should instead be given to providing travellers with clear information on symptoms, routes of transmission, and what to do if symptoms develop after arrival in the EU/EEA. For details, see ECDC Threat Assessment, 21 May 2026.

 

The situation is evolving rapidly! Always stay informed before, during, and after travel! As of 11 June 2026:

  • Avoid non-essential travel to the affected areas in DRC (provinces of Ituri, North Kivu, South Kivu), and to nearby areas in neighboring countries, also due to the security situation (see EDA).
  • For travel in Uganda and the DRC outside the affected areas: Keep yourself regularly updated via official sources. Be aware that conditions can change rapidly. Access to medical care - for accidents, fever, or other health concerns - may be limited and challenging and may involve risks, as may medical evacuation.

The following precautions are recommended for all travel to the DRC and Uganda as well as in neighboring countries:

 

General preventive measures:

  • Wash hands regularly and carefully using soap and water (or alcohol gel if soap is unavailable).
  • Avoid contact with sick people who have symptoms, such as fever, muscle pain, and rash.
  • Avoid contact with blood and other body fluids.
  • Avoid visiting healthcare facilities in the affected areas for nonurgent medical care or non-medical reasons.
  • Avoid contact with dead bodies or items that have been in contact with dead bodies, participating in funeral or burial rituals, or attending a funeral or burial. 
  • Avoid handling, cooking, or eating bush/wild meat (meat of wild/feral mammals killed for food).
  • Wash and peel fruit and vegetables before consumption.
  • Avoid visiting mines or bat caves and contact with all wild animals; alive or dead, particularly bats and the great apes.
  • Practice safer sex.
  • Stay informed for entry and exit requirements by countries, see IATA LINK.
  • If you feel unwell during flight, inform crew immediately and avoid close physical contact with other passengers.

 

Of note: there is currently no licensed vaccine or specific treatment against Ebola diseased caused by Bundibugyo virus. For humanitarian missions, consultation with a travel medicine specialist is recommended.

 

 

While in the affected areas in DRC and in Uganda and for 21 days after leaving:
  • Watch for symptoms (see below).
  • Expect health screening at departure.
  • Stay reachable if contacted by health authorities.
  • Follow quarantine measures established by your local health authorities.

 

! In case of symptoms such as fever or feeling feverish, and any of the following symptoms: headache, body aches, muscle pain, fatigue, loss of appetite, vomiting or diarrhea during your stay in and for 21 days after leaving north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and /or Uganda, especially the affected areas:

  • Separate yourself from others (isolate) immediately.
  • Do not travel.
  • By phone: contact local health authorities or a healthcare facility for a thorough evaluation of your risk (e.g. tropical institute or travel clinic or university hospital infectious disease unit).
  • Always state that you were in the affected areas and you may have had a possible exposure to Ebola (incubation period: 2-21 days). 
  • While under investigation as a suspected case, please also raise the issue of a malaria test and other investigations as necessary based on the exposure region.
  • Details for Ebola disease: see BAG and RKI (in German) or ECDC (in English).

Swiss ECTM recommendations (as of 11 June 2026, subject to change according to the evolving situation):
A suspected case is:

  1. A symptomatic person (see FOPH case definition) with a history of stay within the last 21 days in north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and/or Uganda.    
                              AND
  2. Having had a high-risk exposure* - evaluated by a specialist in infectious diseases or tropical medicine (in case of doubt, contact the Geneva Reference Centre for Emerging Virus Diseases).

Such cases should be isolated, tested, and reported to the Cantonal Physician and the Swiss Federal Office of Public Health within 2 hours.

 

*High-risk exposure includes:

  • Participation in local funerals; or
  • Contact with a sick patient, their body fluids, and/or contaminated material, at home, during transport, or in a healthcare facility; or
  • Attendance at a local healthcare facility.
  • Direct contact with bats, rodents, non-human primates, living or dead, in or from Ebola disease affected areas, or bushmeat.
  • Having unprotected sexual contact with a case up to six months after recovery.

WHO, daily update, accessed 27.5.2026 | WHO DON 21.5.2026 | WHO AFRO, 24.5.2026 | WHO IHR, 22.5.2026 | ECDC | Relief, 27.5.2026
The International Air Transport Association (IATA) continuously updates country-specific entry and exit requirements related to the Ebola disease outbreak in the D.R. Congo and Uganda. For the latest information, please refer to the IATA LINK.
IATA, accessed 3.6.2026

As of 29 May 2026, 197 malaria cases have been reported in Mayotte:

  • 71 suspected locally acquired cases, and
  • 109 imported cases (mostly from the Comoros)
  • 17 cases of undetermined origin.

The predominant species is Plasmodium falciparum. This is a marked increase compared to April 2026. The increase in local transmission represents a setback for Mayotte's malaria elimination efforts.

Optimal mosquito protection 24/7 (at dusk and at night against malaria, during the day against dengue, chikungunya and other arboviruses).

 

In case of fever, malaria should always be ruled out by blood test.

Santé public France, 29.5.2026

Get in touch with us

  • Sekretariat Schweizerische Fachgesellschaft für Tropen- und Reisemedizin,
    Socinstrasse 55, Postfach, 4002 Basel

  • info@healthytravel.ch
  • Ask a specialist
  • News
  • Contact
  • Payment Plans
  • Sponsors
  • Legal notice

Copyright © 2026. All Rights Reserved

0

Bookmarks